M. Drijkoningen
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Estrogen and related hormone effects, Breast Lesions and Carcinomas, Immunotherapy and Immune Responses
Most-Cited Works
- → Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines(2003)200 cited
- → Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer(2005)176 cited
- → Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology(2004)170 cited
- → Polysomy 17 in Breast Cancer: Clinicopathologic Significance and Impact on HER-2 Testing(2008)151 cited
- → The E2F-Regulated Gene Chk1 Is Highly Expressed in Triple-Negative Estrogen Receptor−/Progesterone Receptor−/HER-2− Breast Carcinomas(2007)142 cited
- → Prediction of recurrence after treatment for high‐grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation(2006)138 cited
- → Clinical Relevance of Thyroid Fluorodeoxyglucose-Whole Body Positron Emission Tomography Incidentaloma(2002)119 cited
- → Tobacco Smoking Impairs the Local Immunosurveillance in the Uterine Cervix(1995)110 cited
- Brush cytology of ductal strictures during ERCP.(2001)
- → Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast(2000)95 cited